Synergistic effect of toosendanin and regorafenib against cell proliferation and migration by regulating WWOX signaling pathway in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Synergistic effect of toosendanin and regorafenib against cell proliferation and migration by regulating WWOX signaling pathway in hepatocellular carcinoma

Published:2021-05-31 Issue:8 Volume:35 Page:4567-4578
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Yang Tianfeng¹²,Huo Jian¹²,Xu Rui¹²,Zhang Yanmin¹²^ORCID

Affiliation:

1. School of Pharmacy, Health Science Center Xi'an Jiaotong University Xi'an China

2. State Key Laboratory of Shaanxi for Natural Medicines Research and Engineering Xi'an China

Funder

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7174

Reference30 articles.

1. The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX

2. Clinical Presentation, Risk Factors, and Treatment Modalities of Hepatocellular Carcinoma: A Single Tertiary Care Center Experience

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

4. FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma

5. Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cumulative antitumor effects of regorafenib and radiotherapy in hepatocellular carcinoma;Molecular Carcinogenesis;2024-06-05

2. Toosendanin inhibits T-cell proliferation through the P38 MAPK signalling pathway;European Journal of Pharmacology;2024-06

3. Therapeutic potential of toosendanin: Novel applications of an old ascaris repellent as a drug candidate;Biomedicine & Pharmacotherapy;2023-11

4. Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer;JCI Insight;2022-11-22

5. The therapeutic potential of natural products for treating pancreatic cancer;Frontiers in Pharmacology;2022-11-02